organophosphonates has been researched along with cp 91149 in 1 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (cp 91149) | Trials (cp 91149) | Recent Studies (post-2010) (cp 91149) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 35 | 0 | 17 |
| Protein | Taxonomy | organophosphonates (IC50) | cp 91149 (IC50) |
|---|---|---|---|
| Glycogen phosphorylase, liver form | Homo sapiens (human) | 0.1007 | |
| Glycogen phosphorylase, liver form | Mus musculus (house mouse) | 0.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, T; Hagisawa, Y; Kanda, S; Ogawa, J; Okuno, A; Takahashi, K; Yoshida, T | 1 |
1 other study(ies) available for organophosphonates and cp 91149
| Article | Year |
|---|---|
Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
Topics: Alanine; Amides; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Fasting; Gluconeogenesis; Glucose; Glycogenolysis; Hypoglycemic Agents; Indoles; Lactic Acid; Male; Organophosphonates; Organophosphorus Compounds; Peptide Hydrolases; Rats | 2011 |